2026– date –
-
Cynata Therapeutics Anticipates Announcing iPSC-MSC Clinical Results for Knee Osteoarthritis Phase 3 and Acute GvHD Phase 2 Trials Soon
Regen Report Australia Overview Australian cell therapy company Cynata Therapeutics has announced it will release results from two pivotal clinical trials using its iPSC-derived mesenchymal stem cells (iPSC-MSC) within months. These incl... -
Exosome Therapy Shows Promising Early Clinical Results for Skin Rejuvenation and Hair Loss Treatment, Facing Regulatory Approval Challenges
Skin Therapy Letter USA Overview Exosome therapy, functioning as an intercellular messenger carrying stem cell-derived growth factors and proteins, demonstrates promising early clinical results in both skin rejuvenation and hair loss tre... -
Health Canada Accepts Vertex Pharmaceuticals’ New Drug Submission for Suzetrigine, a Novel NaV1.8 Inhibitor, for Moderate-to-Severe Acute Pain in Adults
BioSpace (via CNW) Canada Overview Vertex Pharmaceuticals announced that Health Canada has accepted its New Drug Submission (NDS) for suzetrigine, a novel oral NaV1.8 selective pain signal inhibitor, for the treatment of moderate-to-seve... -
Intellia Therapeutics Bolsters Market Value with Soaring Stock Price and Improved Financials Amid Positive CRISPR Gene Editing Regulatory Progress
Fintel USA Overview Intellia Therapeutics saw its stock price climb to $12.60 per share, marking a 35.12% year-over-year increase by May 2026, boosting its market capitalization to $1.91 billion. The company also improved its net loss in... -
UCLH Pioneering Gene Editing Therapy Successfully Lowers ‘Bad’ Cholesterol (LDL-C) with Single Dose in Encouraging Early Clinical Trial
University College London Hospitals NHS Foundation Trust UK Overview An early-stage clinical trial at University College London Hospitals (UCLH) has shown promising results where a single dose of gene editing therapy significantly lowere... -
3D-Printed Culture System Accelerates Transplantable Gut Organoid Growth Twofold, Generating Functional Neurons Autonomously
Drug Target Review USA Overview Researchers at Cincinnati Children's Hospital have developed a 3D-printed closed culture system (CCS) that doubles the growth rate of transplantable gut organoids. This novel system produces nearly tenfold... -
Sana Biotechnology Reports 14-Month Positive Clinical Results for Immunosuppression-Free iPSC-Derived Islet Cell Transplant in Type 1 Diabetes
Simply Wall St (via Nasdaq:SANA) USA Overview Sana Biotechnology announced continued positive clinical results from its study of iPSC-derived islet cell transplantation (UP421) for Type 1 diabetes, spanning 14 months without immunosuppre... -
FUJIFILM Cellular Dynamics Quadruples iPSC Manufacturing Capacity with $200M New Facility in Wisconsin, Meeting Soaring Cell Therapy Demand
Manufacturing Dive USA Overview FUJIFILM Cellular Dynamics (FCDI) has inaugurated a new headquarters and iPSC development and manufacturing facility in Madison, Wisconsin, backed by a $200 million investment. This 170,000 square-foot exp... -
CRISPR Gene Editing Evolves with Cas12a2 to Shred Sick Cell DNA, Expanding Therapeutic Horizons for Cancer and Viral Infections
Top Doctor Magazine USA Overview The CRISPR gene editing landscape is rapidly evolving in 2026, driven by the FDA approval of Cas9-based CASGEVY and the discovery of the novel Cas12a2 protein's ability to 'shred' diseased cell DNA. Unlik... -
ASMPT Establishes Technical Advisory Council to Accelerate AI-Era Innovation in Advanced Packaging
ASMPT Singapore Overview ASMPT announced on May 28, 2026, the formation of a Technical Advisory Council (TAC) to accelerate innovation in the AI era. The TAC will provide strategic guidance on advanced packaging roadmaps, including HBM a...
